Antimisiaris Sophia

Studies

1980-1984: BPharm, Dept. of Pharmacy, University of Athens, GR
1984-1988: Ph.D. in Biopharmaceutics Dept of Pharmacy, University of Athens, GR

Positions

2009- : Professor, Department of Pharmacy, UPAT;

2006- : Collaborating Member, Institute of Chemical Engineering, ICEHT-FORTH;

2002-2009: Associate Prof. Dept of Pharmacy, UPAT;

1993-2002 : Assistant Prof. Dept. of Pharmacy, UPAT;

1992-1993 : Visiting Professor, Research associate, Laboratory of Prof. Gregory Gregoriadis, Centre for Drug Delivery Research (CDDR), School of Pharmacy, University of London; UK.

1989-1993 : Lecturer of Pharmaceutics, University of Patras (UPAT);

1988-1989 : Postdoc Research Assistant, Laboratory of Prof. Karl H.L.Hwang, School of Pharmacy, University of South California; LA, USA 

Teaching Activity

Undergraduate Program

Postgraduate Program “EMJMD NANOMED"

• Preformulation
• Pharmaceutical Technology
• Classical and Innovative Formulations
• Nanomedicines

Awards & Distinctions

2019 : Invitation to join the faculty of the PhD Program of Experimental Medicine at University of Pavia.

2019 : Guest Editor for Special Issue: “Overcoming Drug Delivery Problems through Advanced Drug Delivery System Design” in Pharmaceutics (2019-20).

2018 : Invitation to Chair Session "WS-2" in ICONAN Conference, Rome, IT, 2018

2018: Guest Editor for the Special Issue: «Liposomes as Drug Carriers» in Molecules (10-1-2018)

2017 : Invitation as member of the Advisory Board of the School of Pharmacy, University of Catania (IT).

2016 : Invitation (by the group of partners) to be a partner and Coordinator in the research proposal FUSION (submitted as FET open project/H2020, but not funded), which was transformed into the proposal Smart Bone Regeneration (SBR), that has been funded in 2019.

2014 : Short-oral-communication prize for Post-Doc, Dr. S. Mourtas. (Prize: 1000 ILS) at the Israel-Greece Joint Meeting on Nanotechnology BioNanoscience, 20-23.10.2014, Weizmann Institute, Israel.

2012- : Member of the Jury Committee (one of the 70 honorable members) for the Maurice-Marie Janot Honorary Award and Lecture.

2011 : EuroNanoForum Budapest. Best poster award to PI’s student, A. Skouras, http://www. euronanoforum2011.eu/wpcontent/uploads/2010/11/enf11_closingpressrelease_20110601.pdf

2008: Guest Editor for Special Issue: “Nanomedicines” J. Biomedical Nanotechnology, Vol 4.

2008 : Invited (by Coordinator) to participate as a partner and WP-leader in the research proposal NAD (EU-FP7), as the Laboratory for development of liposomal formulations to target the brain (for Alzheimer’s disease).

2008-2016 : 3 Poster or short oral talk prizes in Panhellenic Pharmaceutical Congresses, for young researchers of my group (two for E. Markoutsa and one for K. Papadia).

2006 : Invited (by Coordinator) to participate in the Marie Curie Network Galenos and the proposal “Euro PhD on Advanced Drug Delivery Systems” as a partner and Host Organization for three PhD students.

2003 : Invited to participate as a partner and WP leader, in the research proposal SHIVA (EU-FP6), and suggested by the reviewers as the co-coordinator of the project.

1993: Grant for participation as invited speaker in NATO ASI: "Targeting of Drugs: Advances in System Constructs", Sounio, Greece (1993).

1992-93 : Research Fellowship, University of London (from MOD funded project), London, UK.

1990 : Invited to participate in the Socrates Inter-University Network on Advanced Drug Delivery Systems, by the Coordinator Prof. Rogerio Gaspar (University of Coimbra, PT).

1988-89 : Research Fellowship, from University of South California (from NIH grant), L.A, USA.

Research Activities

• Nanomedicines for Controlled/Targeted Drug Delivery; Innovative nanomedicines Bio-Inspired from Extracellular vesicles;
• Improving Drug Pharmacokinetics through Advanced Drug Delivery (Liposomal) System Design;
• Novel Controlled-(Release)-Drug-Eluting Surfaces for Bioactive agents, Antimicrobials, etc;
• Platform systems for Ocular, Alveolar and Vaginal Drug Delivery Systems, for sustained release of drugs that act locally;
• Elastic Liposomes for penetration in the skin;
• Nanoparticles for Brain targeting, for Cancer or Alzheimer’s disease, diagnosis and/or therapy;
• Improving the anticancer properties of therapeutics by development of targeted carrier systems, with inherit anticancer properties;
• Biocompatible nanoparticles for sustained release of therapeutics/bioactive agents during bone regeneration

Patents

• Liposomes containing particulate materials. WO9509610 (A1) Publication date: 1995-04-1 3/US2002041895 - 2002-04-11 Inventor(s): G. Gregoriadis, S.G. Antimisiaris, I. Gursel. 
• A method for immobilization of bioactive substances on surfaces for improving haemocompatibility. Greek Patent, 2006, Inventor(s): S. G. Antimisiaris, I. Missirlis, G. Michanetzis, G. Koromila. 
• Complex formulations for administration of microbicides or other categories of drugs via mucosal (or vaginal or rectal) routes, with high drug-loading capacity and controllable drug release rates. Greek Patent, 20090100244, 2009, Inventor(s): S.G.Antimisiaris, P.Klepetsanis, S. Mourtas 
• Treatment of Prostate tumors with arsonoliposomes, US Provisional Patent, B1021US00, 2010, Inventors: S.G. Antimisiaris, P.V. Ioannou, M. Wei 
• Novel curcumin derivatives with improved physicochemical properties and surface-decorated Nanoliposomes (with the derivatives) with very high affinity for Amyloid-β1-42 peptide. Greek Patent application 20100100563, 2010, Inventor(s): S.G.Antimisiaris, F. Nicotra, S. Mourtas, C. Zona, B. LaFerla, A. Niaraki 
• System for Sustained release of drugs which is suitable for administration as an injectable or implant. Greek Patent application 2019, Inventor(s): S.G.Antimisiaris, M.Tsilibaris, S. Blazaki, K. Pachis